Human ehrlichiosis

American Family Physician

Volumn 54, Issue 6, 1996, Pages 1971-1976

  Weinstein, Raymond S ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; RIFAMPICIN; TETRACYCLINE;

ANEMIA; CLINICAL FEATURE; EHRLICHIA; EHRLICHIOSIS; LEUKOPENIA; MALAISE; MORTALITY; MYALGIA; REVIEW; THROMBOCYTOPENIA;

ANTI-BACTERIAL AGENTS; EHRLICHIOSIS; HUMANS; TETRACYCLINE;

EID: 0029843808     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Walker DH, Dumler JS. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis 1996;2(1):18-29.
2. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995;20:1102-10.
3. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994;120:736-43.
4. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chafeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 1991;29:2838-42.
5. Harkess JR, Ewing SA, Crutcher JM, et al. Human ehrlichiosis in Oklahoma. J Infect Dis 1989;159:576-9.
6. Yevich SJ, Sanchez JL, DeFraites RF, Rives CC, Dawson JE, Uhaa IJ, et al. Seroepidemiology of infections due to spotted fever group rickettsiae and ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis 1995;171:1266-73.
7. Massachusetts Medical Society. Human granulocytic ehrlichiosis - New York, 1995. MMWR Morb Mortal Weekly Rep 1995;44:593-5.
8. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of granulocytotropic ehrlichia species as the etiologic agent of human disease. J Clin Microbio 1994;32:589-95.
9. Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper midwest United States: a new species emerging? JAMA 1994;272:212-18.
10. Fichtenbaum CJ, Peterson LR, Weil GJ. Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. Am J Med 1993;95:351-7.
11. Eng TR, Harkess JR, Fishbein DB, Dawson JE, Greene CN, Redus MA, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 1990;264:2251-8.
12. Myers SA, Sexton DJ. Dermatologic manifestations of arthropod-borne diseases. Infect Dis Clin North Am 1994;8:689-712
13. Buckner RG, Ewing SA. Experimental treatment of canine ehrlichiosis and haemobartonellosis. J Am Vet Med Assoc 1967;150:1524-30.
14. Standaert SM, Dawson JE, Schaffner W, Childs JE, Biggie KL, Singleton J, et al. Ehrlichiosis in a golf-oriented retirement community. N Engl J Med 1995;333:420-5.
15. Brouqui P, Raoult D. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chafeensis. Antimicrob Agents Chemother 1992;36:2799-2803.
16. Brouqui P, Raoult D. In vitro susceptibility of Ehrlichia sennetsu to antibiotics. Antimicrob Agents Chemother 1990;34:1593-6.